Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation.

Publication Type:

Journal Article


Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Volume 25, Issue 27, p.4246-54 (2007)


Adolescent, Adult, Aged, Comorbidity, Disease-Free Survival, Female, hematopoietic stem cell transplantation, HLA Antigens, Humans, Leukemia, Myeloid, Acute, Male, Middle Aged, Neural Tube Defects, Transplantation, Homologous, Treatment Outcome


Retrospective studies have shown similar survival among patients with acute myeloid leukemia (AML) and myelodysplasia (MDS) after nonmyeloablative compared with myeloablative conditioning. Refined risk stratification is required to design prospective trials.